Skip to main content
Top
Published in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie 5/2022

01-05-2022 | Care | Reports of Original Investigations

The relationship between INTEM/HEPTEM coagulation time ratio and heparin plasma concentration in obstetric patients: an exploratory in vitro investigation

Authors: Daniel Katz, MD, Lisa Leffert, MD, Chloe Getrajdman, MD, Matthew Sison, BS, Da Wi Shin, BE, Hung-Mo Lin, PhD, Alex Butwick, MD

Published in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie | Issue 5/2022

Login to get access

Abstract

Purpose

Unfractionated heparin continues to be one of the main agents used for thromboprophylaxis in obstetrics, which can complicate the placement of neuraxial anesthetics. In this study, we explored the relationship between a point-of-care coagulation test (thromboelastometry) and plasma heparin concentrations in vitro.

Methods

We obtained blood from consenting obstetric patients with uncomplicated pregnancies in their third trimester who were not in labour and had a specific hematocrit range. Blood was processed and analyzed. We added increasing amounts of unfractionated heparin to samples from 0 to 0.3 U·mL−1 in 0.05 U·mL−1 increments to simulate increasing doses of unfractionated heparin. We performed INTEM and HEPTEM testing in parallel with activated partial thromboplastin time (aPTT) testing. We created a model of the relationship between heparin concentration and the INTEM/HEPTEM coagulation time (IH CT) ratio using nonlinear regression. A similar model for aPTT was also created.

Results

Seventy-seven patients were included in the study. Only one concentration of heparin was added to blood samples of each patient. At a concentration of 0.05 U·mL−1, the IH CT ratio was less than or equal to 1.1 in 9/11 (82%) samples. Activated partial thromboplastin time was not prolonged (> 35 sec) until a concentration of 0.1 U·mL−1 heparin was added. In all samples, the IH CT ratio was prolonged at a concentration ≥ 0.2 U·mL−1 as measured by thromboelastometry; however, at no concentration of heparin was aPTT prolonged in all samples.

Conclusion

The point-of-care IH CT ratio may be useful in identifying the presence of little to no heparin activity. Further research is needed to determine if this ratio can predict heparin activity in vivo.
Literature
1.
go back to reference Hoyert DL, Miniño AM. Maternal mortality in the United States: changes in coding, publication, and data release, 2018. Natl Vital Stat Rep 2020; 69: 1-18.PubMed Hoyert DL, Miniño AM. Maternal mortality in the United States: changes in coding, publication, and data release, 2018. Natl Vital Stat Rep 2020; 69: 1-18.PubMed
2.
go back to reference Friedman AM, Ananth CV, Prendergast E, Chauhan SP, D’Alton ME, Wright JD. Thromboembolism incidence and prophylaxis during vaginal delivery hospitalizations. Am J Obstet Gynecol 2015; 212: 221.e1-12. Friedman AM, Ananth CV, Prendergast E, Chauhan SP, D’Alton ME, Wright JD. Thromboembolism incidence and prophylaxis during vaginal delivery hospitalizations. Am J Obstet Gynecol 2015; 212: 221.e1-12.
3.
go back to reference Leffert L, Butwick A, Carvalho B, et al. The Society for Obstetric Anesthesia and Perinatology consensus statement on the anesthetic management of pregnant and postpartum women receiving thromboprophylaxis or higher dose anticoagulants. Anesth Analg 2018; 126: 928-44.CrossRef Leffert L, Butwick A, Carvalho B, et al. The Society for Obstetric Anesthesia and Perinatology consensus statement on the anesthetic management of pregnant and postpartum women receiving thromboprophylaxis or higher dose anticoagulants. Anesth Analg 2018; 126: 928-44.CrossRef
4.
go back to reference Bates SM, Middeldorp S, Rodger M, James AH, Greer I. Guidance for the treatment and prevention of obstetric-associated venous thromboembolism. J Thromb Thrombolysis 2016; 41: 92-128.CrossRef Bates SM, Middeldorp S, Rodger M, James AH, Greer I. Guidance for the treatment and prevention of obstetric-associated venous thromboembolism. J Thromb Thrombolysis 2016; 41: 92-128.CrossRef
5.
go back to reference Brancazio LR, Roperti KA, Stierer R, Laifer SA. Pharmacokinetics and pharmacodynamics of subcutaneous heparin during the early third trimester of pregnancy. Am J Obstet Gynecol 1995; 173: 1240-5.CrossRef Brancazio LR, Roperti KA, Stierer R, Laifer SA. Pharmacokinetics and pharmacodynamics of subcutaneous heparin during the early third trimester of pregnancy. Am J Obstet Gynecol 1995; 173: 1240-5.CrossRef
6.
go back to reference American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Obstetrics; James A, Birsner M, Kaimal A. ACOG Practice Bulletin No. 196. Obstet Gynecol 2018; 132: e1-17. American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Obstetrics; James A, Birsner M, Kaimal A. ACOG Practice Bulletin No. 196. Obstet Gynecol 2018; 132: e1-17.
7.
go back to reference Chunilal SD, Young E, Johnston MA, et al. The APTT response of pregnant plasma to unfractionated heparin. Thromb Haemost 2002; 87: 92-7.CrossRef Chunilal SD, Young E, Johnston MA, et al. The APTT response of pregnant plasma to unfractionated heparin. Thromb Haemost 2002; 87: 92-7.CrossRef
8.
go back to reference Fox NS, Laughon SK, Bender SD, Saltzman DH, Rebarber A. Anti-factor Xa plasma levels in pregnant women receiving low molecular weight heparin thromboprophylaxis. Obstet Gynecol 2008; 112: 884-9.CrossRef Fox NS, Laughon SK, Bender SD, Saltzman DH, Rebarber A. Anti-factor Xa plasma levels in pregnant women receiving low molecular weight heparin thromboprophylaxis. Obstet Gynecol 2008; 112: 884-9.CrossRef
9.
go back to reference Greene LA, Law C, Jung M, et al. Lack of anti-factor Xa assay standardization results in significant low molecular weight heparin (enoxaparin) dose variation in neonates and children. J Thromb Haemost 2014; 12: 1554-7.CrossRef Greene LA, Law C, Jung M, et al. Lack of anti-factor Xa assay standardization results in significant low molecular weight heparin (enoxaparin) dose variation in neonates and children. J Thromb Haemost 2014; 12: 1554-7.CrossRef
10.
go back to reference Collins PW, Cannings-John R, Bruynseels D, et al. Viscoelastometric-guided early fibrinogen concentrate replacement during postpartum haemorrhage: OBS2, a double-blind randomized controlled trial. Br J Anaesth 2017; 119: 411-21.CrossRef Collins PW, Cannings-John R, Bruynseels D, et al. Viscoelastometric-guided early fibrinogen concentrate replacement during postpartum haemorrhage: OBS2, a double-blind randomized controlled trial. Br J Anaesth 2017; 119: 411-21.CrossRef
11.
go back to reference Katz D, Beilin Y. Management of post-partum hemorrhage and the role of the obstetric anesthesiologist. J Matern Fetal Neonatal Med 2021; 34: 1487-93.CrossRef Katz D, Beilin Y. Management of post-partum hemorrhage and the role of the obstetric anesthesiologist. J Matern Fetal Neonatal Med 2021; 34: 1487-93.CrossRef
12.
go back to reference Meesters MI, Lancé MD, van der Steeg R, Boer C. The value of the thromboelastometry heparinase assay (HEPTEM) in cardiac surgery. Thromb Haemost 2015; 114: 1058-63.CrossRef Meesters MI, Lancé MD, van der Steeg R, Boer C. The value of the thromboelastometry heparinase assay (HEPTEM) in cardiac surgery. Thromb Haemost 2015; 114: 1058-63.CrossRef
13.
go back to reference Roullet S, de Maistre E, Ickx B, et al. Position of the French Working Group on Perioperative Haemostasis (GIHP) on viscoelastic tests: what role for which indication in bleeding situations? Anaesth Crit Care Pain Med 2019; 38: 539-48.CrossRef Roullet S, de Maistre E, Ickx B, et al. Position of the French Working Group on Perioperative Haemostasis (GIHP) on viscoelastic tests: what role for which indication in bleeding situations? Anaesth Crit Care Pain Med 2019; 38: 539-48.CrossRef
14.
go back to reference Mittermayr M, Margreiter J, Velik-Salchner C, et al. Effects of protamine and heparin can be detected and easily differentiated by modified thrombelastography (Rotem®): an in vitro study. Br J Anaesth 2005; 95: 310-6.CrossRef Mittermayr M, Margreiter J, Velik-Salchner C, et al. Effects of protamine and heparin can be detected and easily differentiated by modified thrombelastography (Rotem®): an in vitro study. Br J Anaesth 2005; 95: 310-6.CrossRef
15.
go back to reference Ichikawa J, Kodaka M, Nishiyama K, Hirasaki Y, Ozaki M, Komori M. Reappearance of circulating heparin in whole blood heparin concentration-based management does not correlate with postoperative bleeding after cardiac surgery. J Cardiothorac Vasc Anesth 2014; 28: 1003-7.CrossRef Ichikawa J, Kodaka M, Nishiyama K, Hirasaki Y, Ozaki M, Komori M. Reappearance of circulating heparin in whole blood heparin concentration-based management does not correlate with postoperative bleeding after cardiac surgery. J Cardiothorac Vasc Anesth 2014; 28: 1003-7.CrossRef
16.
go back to reference McQuaid E, Leffert LR, Bateman BT. The role of the anesthesiologist in preventing severe maternal morbidity and mortality. Clin Obstet Gynecol 2018; 61: 372-86.CrossRef McQuaid E, Leffert LR, Bateman BT. The role of the anesthesiologist in preventing severe maternal morbidity and mortality. Clin Obstet Gynecol 2018; 61: 372-86.CrossRef
17.
go back to reference Finley A, Greenberg C. Review article: heparin sensitivity and resistance: management during cardiopulmonary bypass. Anesth Analg 2013; 116: 1210-22.CrossRef Finley A, Greenberg C. Review article: heparin sensitivity and resistance: management during cardiopulmonary bypass. Anesth Analg 2013; 116: 1210-22.CrossRef
18.
go back to reference Whitfield LR, Lele AS, Levy G. Effect of pregnancy on the relationship between concentration and anticoagulant action of heparin. Clin Pharmacol Ther 1983; 34: 23-8.CrossRef Whitfield LR, Lele AS, Levy G. Effect of pregnancy on the relationship between concentration and anticoagulant action of heparin. Clin Pharmacol Ther 1983; 34: 23-8.CrossRef
19.
go back to reference Delavenne X, Ollier E, Chollet S, et al. Pharmacokinetic/pharmacodynamic model for unfractionated heparin dosing during cardiopulmonary bypass. Br J Anaesth 2017; 118: 705-12.CrossRef Delavenne X, Ollier E, Chollet S, et al. Pharmacokinetic/pharmacodynamic model for unfractionated heparin dosing during cardiopulmonary bypass. Br J Anaesth 2017; 118: 705-12.CrossRef
Metadata
Title
The relationship between INTEM/HEPTEM coagulation time ratio and heparin plasma concentration in obstetric patients: an exploratory in vitro investigation
Authors
Daniel Katz, MD
Lisa Leffert, MD
Chloe Getrajdman, MD
Matthew Sison, BS
Da Wi Shin, BE
Hung-Mo Lin, PhD
Alex Butwick, MD
Publication date
01-05-2022
Publisher
Springer International Publishing
Keywords
Care
Heparin
Published in
Canadian Journal of Anesthesia/Journal canadien d'anesthésie / Issue 5/2022
Print ISSN: 0832-610X
Electronic ISSN: 1496-8975
DOI
https://doi.org/10.1007/s12630-022-02193-5

Other articles of this Issue 5/2022

Canadian Journal of Anesthesia/Journal canadien d'anesthésie 5/2022 Go to the issue